Sivakumar S, Lieber S, Dietze R, Beutgen V, Sutor E, Heidemann S
Cell Commun Signal. 2025; 23(1):136.
PMID: 40082910
PMC: 11907816.
DOI: 10.1186/s12964-025-02128-9.
Choi B, Jo M, Shin H, Park S
Molecules. 2025; 30(5).
PMID: 40076212
PMC: 11901821.
DOI: 10.3390/molecules30050987.
Jiao J, Wu Y, Wu S, Jiang J
Curr Treat Options Oncol. 2025; .
PMID: 40045029
DOI: 10.1007/s11864-025-01306-8.
Dabrowska M, Kepczynska A, Gozdzik K, Nowak N, Uram L, Skoneczny M
Histochem Cell Biol. 2025; 163(1):33.
PMID: 40029443
DOI: 10.1007/s00418-025-02363-8.
Sharma V, Gupta A, Singh A, Tyagi S, Panday H, Srivastava S
In Silico Pharmacol. 2025; 13(1):33.
PMID: 40018381
PMC: 11861490.
DOI: 10.1007/s40203-025-00315-7.
Clinical Progress of Fruquintinib in Colorectal Cancer: An Overview.
Xie Y, Tang S, Qin Z, Yang C
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006092
PMC: 11859084.
DOI: 10.3390/ph18020280.
Bioinformatic analysis and experimental validation implicate STAT2-mediated angiogenic responses in rosacea pathogenesis.
Chen B, Wu C, Liao Y, Hu H, Liu X, Chen C
Arch Dermatol Res. 2025; 317(1):398.
PMID: 39945902
DOI: 10.1007/s00403-025-03915-7.
Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models.
Lin S, Tang R, Ye Y, Xia C, Wu J, Duan R
Molecules. 2025; 30(2).
PMID: 39860127
PMC: 11767819.
DOI: 10.3390/molecules30020257.
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs).
He Q, Lin J, Mo C, Li G, Lu J, Sun Q
Front Pharmacol. 2025; 15():1463520.
PMID: 39850566
PMC: 11754196.
DOI: 10.3389/fphar.2024.1463520.
New insight in immunotherapy and combine therapy in colorectal cancer.
Ji K, Jia H, Liu Z, Yu G, Wen R, Zhang T
Front Cell Dev Biol. 2025; 12():1453630.
PMID: 39839672
PMC: 11747282.
DOI: 10.3389/fcell.2024.1453630.
Tumor Microenvironment Responsive Key Nanomicelles for Effective Against Invasion and Metastasis in Ovarian Cancer Using Mice Model.
Liu Y, Kong L, Yu Y, Zang J, Zhang L, Guo R
Int J Nanomedicine. 2025; 20():215-238.
PMID: 39802386
PMC: 11724672.
DOI: 10.2147/IJN.S470219.
Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy.
Yan T, Shi J
Front Immunol. 2024; 15:1509195.
PMID: 39737184
PMC: 11682976.
DOI: 10.3389/fimmu.2024.1509195.
New insights into the role of ubiquitination in angiogenesis (Review).
Chen T, Wang K, Sun Z
Int J Mol Med. 2024; 55(2).
PMID: 39704208
PMC: 11670862.
DOI: 10.3892/ijmm.2024.5473.
Research progress on FSH-FSHR signaling in the pathogenesis of non-reproductive diseases.
Li C, Ling Y, Kuang H
Front Cell Dev Biol. 2024; 12:1506450.
PMID: 39633710
PMC: 11615068.
DOI: 10.3389/fcell.2024.1506450.
Biological strategies in rotator cuff repair: a clinical application and molecular background.
Pawlak M, Walecka J, Lubiatowski P
EFORT Open Rev. 2024; 9(12):1156-1169.
PMID: 39620574
PMC: 11619734.
DOI: 10.1530/EOR-24-0012.
Minimally Invasive Syringe-Injectable Hydrogel with Angiogenic Factors for Ischemic Stroke Treatment.
Kim D, Lee J, Kim Y, Choe J, Kim G, Ha C
Adv Healthc Mater. 2024; 14(6):e2403119.
PMID: 39520382
PMC: 11874675.
DOI: 10.1002/adhm.202403119.
Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis.
Zhang Y, Shu P, Wang X, Ouyang G, Zhou J, Zhao Y
J Cancer. 2024; 15(19):6326-6335.
PMID: 39513111
PMC: 11540501.
DOI: 10.7150/jca.100653.
Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model.
Schmid K, Zeinali S, Moser S, Dubey C, Schneider S, Deng H
Front Bioeng Biotechnol. 2024; 12:1457884.
PMID: 39439549
PMC: 11493642.
DOI: 10.3389/fbioe.2024.1457884.
Research progress of ankyrin repeat domain 1 protein: an updated review.
Xu X, Wang X, Li Y, Chen R, Wen H, Wang Y
Cell Mol Biol Lett. 2024; 29(1):131.
PMID: 39420247
PMC: 11488291.
DOI: 10.1186/s11658-024-00647-w.
Dual Role of Necroptosis in Cervical Cancer: Promoting Tumor Aggression and Modulating the Immune Microenvironment via the JAK2-STAT3 Pathway.
Xu F, Ye Y, Gao Y, Xu S
J Cancer. 2024; 15(16):5288-5307.
PMID: 39247606
PMC: 11375541.
DOI: 10.7150/jca.98738.